AXSM vs EMR · rev $409.6M vs P/E 34, rev $4.86B
Axsome Therapeutics Inc (AXSM) versus Emerson Electric Company (EMR) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
AXSM currently screens at market cap $11.96B. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Not investment advice. Open the AXSM and EMR stock pages for the full models.
Not investment advice.